Maximum quantity allowed is 999
请选择数量
CAS RN: 321-64-2 | 產品號碼: T3994
| 產品號碼 | T3994 |
| 純度/分析方法 | >98.0%(T)(HPLC) |
| 分子式 / 分子量 | C__1__3H__1__4N__2 = 198.27 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件 | Room Temperature (Recommended in a cool and dark place, <15°C) |
| 儲存在惰性氣體下 | Store under inert gas |
| 應避免的情況 | Air Sensitive |
| 包裝和容器 | 1G-Glass Bottle with Plastic Insert （閲覽圖片）, 250MG-Glass Bottle with Plastic Insert （閲覽圖片） |
| CAS RN | 321-64-2 |
| Reaxys-RN | 147610 |
| PubChem Substance ID | 468593059 |
| MDL編號 | MFCD00046923 |
產品規格
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Melting point | 181.0 to 185.0 °C |
| NMR | confirm to structure |
性質
| 熔點 | 183 °C |
| Maximum Wavelength | 325 nm (EtOH) |
GHS
| 圖形表示 |
|
| 信號詞 | Danger |
| 危險性說明 | H301 : Toxic if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
| 防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
相關法規
| RTECS # | AR9532100 |
運輸資料
| UN編號 | UN2811 |
| 類別 | 6.1 |
| 包裝類別 | III |
| HS編碼* | 2933.99-000 |
Application
Mitochondria research
References
- Tacrine Inhibits Topoisomerases and DNA Synthesis to Cause Mitochondrial DNA Depletion and Apoptosis in Mouse Liver
- Uncoupling of Rat and Human Mitochondria: A Possible Explanation for Tacrine-Induced Liver Dysfunction
Application
Tacrine: A Reversible Cholinesterase Inhibitor
Tacrine is a reversible cholinesterase inhibitor, and the first approved agent for the treatment of Alzheimer's disease.1) The mechanism of action of tacrine is thought to inhibit the metabolism of acetylcholine and therefore extending its activity and raising levels in the cerebral cortex.2,3) However, since tacrine shows various side effects and toxicity, the development of the next generation inhibitors such as donepezil [D4099 (HCl salt)] is underway.3,4) (The product is for research purpose only.)
References
- 1) Tacrine
- 2) Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease
- 3) A review on cholinesterase inhibitors for Alzheimer's disease
- 4) A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。